Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment of Recurrent Ovarian Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00979992
What this trial is testing

Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaRecurrent Ovarian Carcinoma
National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00002901
What this trial is testing

Docetaxel in Treating Patients With Solid Tumors and Abnormal Liver Function

Who this might be right for
Breast CancerHead and Neck CancerLung Cancer+2 more
City of Hope Medical Center
Not applicableStudy completedNCT03270995
What this trial is testing

Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+1 more
McGill University 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT05467670
What this trial is testing

Safety and Efficacy of Anti-CD47, ALX148 in Combination With Liposomal Doxorubicin and Pembrolizumab in Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer
Alexander B Olawaiye, MD 16
Early research (Phase 1)Study completedNCT00346385
What this trial is testing

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Ovarian CancerMerkel Cell CarcinomaSCLC
ImmunoGen, Inc. 97
Testing effectiveness (Phase 2)Study completedNCT00888615
What this trial is testing

Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+15 more
GOG Foundation 58
Testing effectiveness (Phase 2)Study completedNCT03759587
What this trial is testing

Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Takeda 19
Testing effectiveness (Phase 2)Ended earlyNCT00002478
What this trial is testing

Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Who this might be right for
Cervical CancerOvarian Cancer
Gynecologic Oncology Group
Not applicableNot Yet RecruitingNCT05921149
What this trial is testing

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerChemotherapeutic Toxicity
Endeavor Health 170
Early research (Phase 1)Ended earlyNCT02476955
What this trial is testing

Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole

Who this might be right for
Solid TumorsOvarian CancerEndometrial Cancer
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 41
Very early researchStudy completedNCT01132014
What this trial is testing

Autologous OC-DC Vaccine in Ovarian Cancer

Who this might be right for
ChemotherapyTumorOvarian Cancer
Abramson Cancer Center at Penn Medicine 67
Early research (Phase 1)UnknownNCT01387399
What this trial is testing

Safety and Pharmacokinetics of Intraoperative Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) With Cisplatin to Treat Platinum-sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
University Hospital, Bonn 9
Testing effectiveness (Phase 2)Study completedNCT00005952
What this trial is testing

Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorHead and Neck Cancer+5 more
Duke University 30
Testing effectiveness (Phase 2)Ended earlyNCT04019288
What this trial is testing

AVB-S6-500 and Durvalumab in Treating Patients With Platinum-Resistant or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Platinum-Resistant Fallopian Tube CarcinomaPlatinum-Resistant Ovarian CarcinomaPlatinum-Resistant Primary Peritoneal Carcinoma+6 more
M.D. Anderson Cancer Center 12
Testing effectiveness (Phase 2)Looking for participantsNCT07480954
What this trial is testing

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal CarcinomaFallopian Tube Carcinoma+1 more
Beijing Biotech 36
Testing effectiveness (Phase 2)UnknownNCT05311579
What this trial is testing

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

Who this might be right for
Ovarian CarcinomaSurvival OutcomesAdverse Events+6 more
Lei Li 36
Testing effectiveness (Phase 2)Ended earlyNCT00006262
What this trial is testing

Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial Cancer

Who this might be right for
Ovarian Cancer
Northwestern University
Early research (Phase 1)UnknownNCT03542669
What this trial is testing

Study of 6b11-OCIK Injection Treatment in Patients With Recurrent Drug-resistant Ovarian Cancer

Who this might be right for
Recurrent Ovarian CarcinomaPlatinum-resistant Ovarian Cancer
Peking University People's Hospital 9
Early research (Phase 1)Looking for participantsNCT07030907
What this trial is testing

Evaluate the Safety and Efficacy of OPB-101 in Platinum-resistant Ovarian Cancer

Who this might be right for
Ovarian Cancer RecurrentOvarian CancerPlatinum Resistant Ovarian Cancer
Outpace Bio, Inc. 30
Testing effectiveness (Phase 2)Ended earlyNCT00003852
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorOvarian Cancer+1 more
UNICANCER 45
Next Page